|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: INTERMUNE PHARMACEUTICALS INC, 10-Q, 2000-10-30 |
Next: INTERMUNE PHARMACEUTICALS INC, POS AM, 2000-10-30 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from financial
statements for the nine-month period ending September 30, 2000, and is qualified
in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<EXCHANGE-RATE> 1.00
<CASH> 197,351
<SECURITIES> 0
<RECEIVABLES> 1,813
<ALLOWANCES> (278)
<INVENTORY> 1,200
<CURRENT-ASSETS> 203,485
<PP&E> 860
<DEPRECIATION> (94)
<TOTAL-ASSETS> 204,501
<CURRENT-LIABILITIES> 4,361
<BONDS> 0
0
0
<COMMON> 24
<OTHER-SE> 200,116
<TOTAL-LIABILITY-AND-EQUITY> 204,501
<SALES> 6,964
<TOTAL-REVENUES> 6,964
<CGS> (5,174)
<TOTAL-COSTS> 0
<OTHER-EXPENSES> (24,809)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (161)
<INCOME-PRETAX> (17,948)
<INCOME-TAX> 0
<INCOME-CONTINUING> (17,948)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (17,948)
<EPS-BASIC> (3.03)
<EPS-DILUTED> (3.03)
</TABLE>
|
|